This inventor holds 2 USPTO granted patents. Top assignee: Promega Corporation. Active years: 2004-2008.
Company Filing History:
Years Active: 2004-2008
Title: Innovations by Allan Tereba
Introduction
Allan Tereba is an accomplished inventor based in Fitchburg, WI (US). He has made significant contributions to the field of biotechnology, particularly in the areas of sperm cell isolation and DNA quantitation. With a total of 2 patents, Tereba's work has the potential to impact various applications in medical and biological research.
Latest Patents
Tereba's latest patents include innovative methods and kits for isolating sperm cells from aqueous samples. These methods provide a streamlined approach to obtaining viable sperm cells for various applications. Additionally, he has developed a method for the simultaneous isolation and quantitation of DNA target material. This invention utilizes silica magnetic particles to form a complex with DNA, allowing for efficient separation and elution of the target material. The process eliminates the need for prior quantitation of biological samples, simplifying subsequent analyses such as DNA sequencing.
Career Highlights
Throughout his career, Allan Tereba has been associated with Promega Corporation, a leading company in the biotechnology sector. His work has contributed to advancements in genetic research and reproductive technologies. Tereba's innovative approaches have garnered attention within the scientific community, showcasing his expertise in the field.
Collaborations
Tereba has collaborated with notable colleagues, including Rex M Bitner and Susan C Koller. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.
Conclusion
Allan Tereba's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative methods for isolating sperm cells and quantifying DNA target material demonstrate the potential for advancements in medical and biological research.